Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats

Journal of Endocrinology

Volumn 220, Issue 3, 2014, Pages 345-359

  Kurtz, M ^a   Capobianco, E ^a   Careaga, V ^b   Martinez, N ^a   Mazzucco, M B ^a   Maier, M ^b   Jawerbaum, A ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Diabetes in pregnancy; Fetus; Lipids; Lung; PPAR

Indexed keywords

DIABETES IN PREGNANCY; FETUS; LIPIDS; LUNG; PPAR;

ANIMALS; DIABETES, GESTATIONAL; FEMALE; FETUS; LEUKOTRIENE B4; LIGANDS; LIPID METABOLISM; LIPIDS; LUNG; MALE; PLANT OILS; PPAR ALPHA; PPAR GAMMA; PREGNANCY; PROSTAGLANDIN D2; RATS; RATS, WISTAR; SAFFLOWER OIL;

EID: 84894300107     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0362     Document Type: Article

References (62)

1. Ali S& Dornhorst A 2011 Diabetes in pregnancy: health risks and management. Postgraduate Medical Journal 87 417-427. (doi:10.1136/pgmj.2010.109157)
2. Becker J, Delayre-Orthez C, Frossard N&Pons F 2006 Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fundamental & Clinical Pharmacology 20 429-447. (doi:10.1111/j.1472-8206.2006.00425.x)
3. Belvisi MG&Hele DJ 2008 Peroxisome proliferator-activated receptors as novel targets in lung disease. Chest 134 152-157. (doi:10.1378/chest.08-0019)
4. Benz V, Kintscher U&Foryst-Ludwig A 2012 Sex-specific differences in type 2 diabetes mellitus and dyslipidemia therapy: PPAR agonists. Handbook of Experimental Pharmacology 214 387-410. (doi:10.1007/978-3-642-30726-3_18)
5. Bourbon JR&Farrell PM 1985 Fetal lung development in the diabetic pregnancy. Pediatric Research 19 253-267. (doi:10.1203/00006450-198503000-00001)
6. Bresson E, Seaborn T, Cote M, Cormier G, Provost PR, Piedboeuf B & Tremblay Y 2010 Gene expression profile of androgen modulated genes in the murine fetal developing lung. Reproductive Biology and Endocrinology 8 2. (doi:10.1186/1477-7827-8-2)
7. Capobianco E, Jawerbaum A, Romanini MC, White V, Pustovrh C, Higa R, Martinez N, Mugnaini MT, Sonez C&Gonzalez E 2005 15-Deoxy-D12,14-prostaglandin J2 and peroxisome proliferator-activated receptor g (PPARg) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARg agonist on nitridergic and lipid placental metabolism. Reproduction, Fertility, and Development 17 423-433. (doi:10.1071/RD04067)
8. Capobianco E, Martinez N, Fornes D, Higa R, Marco ID, Basualdo MN, Faingold MC&Jawerbaum A 2013 PPAR activation as a regulator of lipid metabolism, nitric oxide production and lipid peroxidation in the placenta from type 2 diabetic patients. Molecular and Cellular Endocrinology 377 7-15. (doi:10.1016/j.mce.2013.06.027)
9. Careaga VP, Muniain C&Maier MS 2013 Fatty acid composition of the edible sea cucumber Athyonidium chilensis. Natural Product Research 27 639-647. (doi:10.1080/14786419.2012.686909)
10. Carey MA, Card JW, Voltz JW, Arbes SJ Jr, Germolec DR, Korach KS&Zeldin DC 2007 It's all about sex: gender, lung development and lung disease. Trends in Endocrinology and Metabolism 18 308-313. (doi:10.1016/j.tem.2007.08.003)
11. Chao AC, Ziadeh BI, Diau GY, Wijendran V, Sarkadi-Nagy E, Hsieh AT, Nathanielsz PW&Brenna JT 2003 Influence of dietary long-chain PUFA on premature baboon lung FA and dipalmitoyl PC composition. Lipids 38 425-429. (doi:10.1007/s11745-003-1079-8)
12. Chen H, Jackson S, Doro M&McGowan S 1998 Perinatal expression of genes that may participate in lipid metabolism by lipid-laden lung fibroblasts. Journal of Lipid Research 39 2483-2492.
13. Cheng L, Ding G, Qin Q, Xiao Y, Woods D, Chen YE&Yang Q 2004 Peroxisome proliferator-activated receptor d activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochemical and Biophysical Research Communications 313 277-286. (doi:10.1016/j.bbrc.2003.11.127)
14. Desvergne B, Michalik L&Wahli W 2006 Transcriptional regulation of metabolism. Physiological Reviews 86 465-514. (doi:10.1152/physrev.00025.2005)
15. Garcia-Patterson A, Aulinas A, Sojo L, Ginovart G, Adelantado JM, de Leiva A&Corcoy R 2011 Poorer perinatal outcome in male newborns of women with pregestational diabetes mellitus. Diabetic Medicine 28 436-439. (doi:10.1111/j.1464-5491.2011.03227.x)
16. Herrera E&Ortega-Senovilla H 2010 Disturbances in lipid metabolism in diabetic pregnancy - are these the cause of the problem? Best Practice&Research. Clinical Endocrinology and Metabolism 24 515-525. (doi:10.1016/j.beem.2010.05.006)
17. Herrera E, Amusquivar E, Lopez-Soldado I&Ortega H 2006 Maternal lipid metabolism and placental lipid transfer. Hormone Research 65(Suppl 3) 59-64. (doi:10.1159/000091507)
18. Higa R&Jawerbaum A 2013 Intrauterine effects of impaired lipid homeostasis in pregnancy diseases. Current Medicinal Chemistry 20 2338-2350. (doi:10.2174/0929867311320180005)
19. Hihi AK, Michalik L & Wahli W 2002 PPARs: transcriptional effectors of fatty acids and their derivatives. Cellular and Molecular Life Sciences 59 790-798. (doi:10.1007/s00018-002-8467-x)
20. Hwang D & Rhee SH 1999 Receptor-mediated signaling pathways: potential targets of modulation by dietary fatty acids. American Journal of Clinical Nutrition 70 545-556.
21. Jawerbaum A&Capobianco E 2011 Review: Effects of PPAR activation in the placenta and the fetus: implications in maternal diabetes. Placenta 32(Suppl 2) S212-S217. (doi:10.1016/j.placenta.2010.12.002)
22. Jawerbaum A&Gonzalez E 2006 Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Current Medicinal Chemistry 13 2127-2138. (doi:10.2174/092986706777935302)
23. Jawerbaum A&White V 2010 Animal models in diabetes and pregnancy. Endocrine Reviews 31 680-701. (doi:10.1210/er.2009-0038)
24. Jawerbaum A, Capobianco E, Pustovrh C, White V, Baier M, Salzberg S, Pesaresi M&Gonzalez E 2004 Influence of peroxisome proliferatoractivated receptor g activation by its endogenous ligand 15-deoxy D12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Molecular Human Reproduction 10 671-676. (doi:10.1093/molehr/gah090)
25. Kautzky-Willer A&Handisurya A 2009 Metabolic diseases and associated complications: sex and gender matter!. European Journal of Clinical Investigation 39 631-648. (doi:10.1111/j.1365-2362.2009.02161.x)
26. Kobayashi M, Gouda K, Chisaki I, Ochiai M, Itagaki S&Iseki K 2011 Regulation mechanism of ABCA1 expression by statins in hepatocytes. European Journal of Pharmacology 662 9-14. (doi:10.1016/j.ejphar.2011.04.043)
27. Koskinen A, Laiho A, Lukkarinen H, Kaapa P & Soukka H 2010 Maternal hyperglycemia modifies extracellular matrix signaling pathways in neonatal rat lung. Neonatology 98 387-396. (doi:10.1159/000317010)
28. Koskinen A, Lukkarinen H, Moritz N, Aho H, Kaapa P&Soukka H 2012 Fetal hyperglycemia alters lung structural development in neonatal rat. Pediatric Pulmonology 47 275-282. (doi:10.1002/ppul.21541)
29. Kurtz M, Martinez N, Capobianco E, Higa R, Fornes D, White V & Jawerbaum A 2012 Increased nitric oxide production and genderdependent changes in PPARa expression and signaling in the fetal lung from diabetic rats. Molecular and Cellular Endocrinology 362 120-127. (doi:10.1016/j.mce.2012.05.018)
30. Lappas M, Hiden U, Desoye G, Froehlich J, Mouzon SH & Jawerbaum A 2011 The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxidants and Redox Signaling 15 3061-3100. (doi:10.1089/ars.2010.3765)
31. Lefebvre P, Chinetti G, Fruchart JC&Staels B 2006 Sorting out the roles of PPARa in energy metabolism and vascular homeostasis. Journal of Clinical Investigation 116 571-580. (doi:10.1172/JCI27989)
32. Lillycrop KA, Phillips ES, Jackson AA, Hanson MA&Burdge GC 2005 Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. Journal of Nutrition 135 1382-1386.
33. Liu J, Sakurai R, O'Roark EM, Kenyon NJ, Torday JS & Rehan VK 2011 PPARg agonist rosiglitazone prevents perinatal nicotine exposureinduced asthma in rat offspring. American Journal of Physiology. Lung Cellular and Molecular Physiology 300 L710-L717. (doi:10.1152/ajplung.00337.2010)
34. Luconi M, Cantini G&Serio M 2010 Peroxisome proliferator-activated receptor g (PPARg): is the genomic activity the only answer? Steroids 75 585-594. (doi:10.1016/j.steroids.2009.10.012)
35. Martinez N, KurtzM, Capobianco E, Higa R, White V&JawerbaumA 2011a PPARa agonists regulate lipid metabolism and nitric oxide production and prevent placental overgrowth in term placentas from diabetic rats. Journal of Molecular Endocrinology 47 1-12. (doi:10.1530/JME-10-0173)
36. Martinez N, White V, Kurtz M, Higa R, Capobianco E & JawerbaumA 2011b Activation of the nuclear receptor PPARa regulates lipid metabolism in foetal liver from diabetic rats: implications in diabetes-induced foetal overgrowth. Diabetes/Metabolism Research and Reviews 27 35-46. (doi:10.1002/dmrr.1151)
37. Martinez N, Sosa M, Higa R, Fornes D, Capobianco E & Jawerbaum A 2012 Dietary treatments enriched in olive and safflower oils regulate seric and placental matrix metalloproteinases in maternal diabetes. Placenta 33 8-16. (doi:10.1016/j.placenta.2011.10.015)
38. Milla CE&Zirbes J 2012 Pulmonary complications of endocrine and metabolic disorders. Paediatric Respiratory Reviews 13 23-28. (doi:10.1016/j.prrv.2011.01.004)
39. Narala VR, Adapala RK, Suresh MV, Brock TG, Peters-GoldenM& Reddy RC 2010 Leukotriene B4 is a physiologically relevant endogenousperoxisome proliferator-activated receptor-a agonist. Journal of Biological Chemistry 285 22067-22074. (doi:10.1074/jbc.M109.085118)
40. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T et al. 2010 Pathological aspects of lipid peroxidation. Free Radical Research 44 1125-1171. (doi:10.3109/10715762.2010.498478)
41. Oosthuyse,Bosch AN 2012 Oestrogen's regulation of fat metabolism during exercise and gender specific effects. Current Opinion in Pharmacology 12 363-371. (doi:10.1016/j.coph.2012.02.008)
42. Piper JM 2002 Lung maturation in diabetes in pregnancy: if and when to test. Seminars in Perinatology 26 206-209. (doi:10.1053/sper.2002.33969)
43. Pustovrh MC, Capobianco E, Martinez N, Higa R, White,Jawerbaum A 2009 MMP/TIMPbalance is modulated in vitro by 15dPGJ2 in fetuses and placentas from diabetic rats. European Journal of Clinical Investigation 39 1082-1090. (doi:10.1111/j.1365-2362.2009.02200.x)
44. Reddy AT, Lakshmi SP, Kleinhenz JM, Sutliff RL, Hart CM& Reddy RC 2012 Endothelial cell peroxisome proliferator-activated receptor g reduces endotoxemic pulmonary inflammation and injury. Journal of Immunology 189 5411-5420. (doi:10.4049/jimmunol.1201487)
45. Rehan VK&Torday JS 2012 PPARg signaling mediates the evolution, development, homeostasis, and repair of the lung. PPAR Research 2012 289867. (doi:10.1155/2012/289867)
46. Robert MF, Neff RK, Hubbell JP, Taeusch HW& Avery ME 1976 Association between maternal diabetes and the respiratory-distress syndrome in the newborn. New England Journal of Medicine 294 357-360. (doi:10.1056/NEJM197602122940702)
47. Rooney SA, Young SL&Mendelson CR 1994 Molecular and cellular processing of lung surfactant. FASEB Journal 8 957-967.
48. Rudiger M, von Baehr A, Haupt R, Wauer RR & Rustow B 2000 Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Critical Care Medicine 28 1572-1577. (doi:10.1097/00003246-200005000-00052)
49. Salas A, Noe V, Ciudad CJ, Romero MM, Remesar X&EsteveM2007 Shortterm oleoyl-estrone treatment affects capacity to manage lipids in rat adipose tissue. BMC Genomics 8 292. (doi:10.1186/1471-2164-8-292)
50. Schaefer MB, Pose A, Ott J, Hecker M, Behnk A, Schulz R, Weissmann N, Gunther A, SeegerW& Mayer K 2008 Peroxisome proliferator-activated receptor-a reduces inflammation and vascular leakage in a murine model of acute lung injury. European Respiratory Journal 32 1344-1353. (doi:10.1183/09031936.00035808)
51. Scher JU&Pillinger MH 2005 15d-PGJ2: the anti-inflammatory prostaglandin? Clinical Immunology 114 100-109. (doi:10.1016/j.clim.2004.09.008)
52. Seaborn T, Simard M, Provost PR, Piedboeuf B&Tremblay Y 2010 Sex hormone metabolism in lung development and maturation. Trends in Endocrinology and Metabolism 21 729-738. (doi:10.1016/j.tem.2010.09.001)
53. Sharma S, Chhibber S&Mohan H 2013 Dietary supplementation with u-3 polyunsaturated fatty acids ameliorates acute pneumonia induced by Klebsiella pneumoniae in BALB/c mice. Canadian Journal of Microbiology 59 503-510. (doi:10.1139/cjm-2012-0521)
54. Simeoni U&Barker DJ 2009 Offspring of diabetic pregnancy: long-term outcomes. Seminars in Fetal&Neonatal Medicine 14 119-124. (doi:10.1016/j.siny.2009.01.002)
55. Sosenko IR, Innis SM&Frank L 1988 Polyunsaturated fatty acids and protection of newborn rats from oxygen toxicity. Journal of Pediatrics 112 630-637. (doi:10.1016/S0022-3476(88)80186-0)
56. Sosenko IR, Innis SM&Frank L 1991 Intralipid increases lung polyunsaturated fatty acids and protects newborn rats from oxygen toxicity. Pediatric Research 30 413-417. (doi:10.1203/00006450-199111000-00004)
57. Trevino-Alanis M, Ventura-Juarez J, Hernandez-Pinero J, Nevarez-Garza A, Quintanar-Stephano A & Gonzalez-Pina A 2009 Delayed lung maturation of foetus of diabetic mother rats develop with a diminish,peroxisome proliferator-activated receptor-a agonist. Journal of Biological Chemistry 285 22067-22074. (doi:10.1074/jbc.M109.085118)
58. Vela-Huerta M, Aguilera-Lopez A, Alarcon-Santos S, Amador N, Aldana-Valenzuela C & Heredia A 2007 Cardiopulmonary adaptation in large for gestational age infants of diabetic and nondiabetic mothers. Acta Paediatrica 96 1303-1307. (doi:10.1111/j.1651-2227.2007.00414.x)
59. Wagner MC, Yeligar SM, Brown LA & Michael Hart C 2012 PPARg ligands regulate NADPH oxidase, eNOS, and barrier function in the lungfollowing chronic alcohol ingestion. Alcoholism, Clinical and Experimental Research 36 197-206. (doi:10.1111/j.1530-0277.2011.01599.x)
60. Wahli W & Michalik L 2012 PPARs at the crossroads of lipid signaling and inflammation. Trends in Endocrinology and Metabolism 23 351-363. (doi:10.1016/j.tem.2012.05.001)
61. Weindling AM2009 Offspring of diabetic pregnancy: short-term outcomes. Seminars in Fetal and Neonatal Medicine 14 111-118. (doi:10.1016/j.siny.2008.11.007)
62. Yoon M 2009 The role of PPARa in lipid metabolism and obesity: focusing on the effects of estrogen on PPARa actions. Pharmacological Research 60 151-159. (doi:10.1016/j.phrs.2009.02.004)